Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Short intravenous administration of LPS in humans has induced a storm of cardiovascular hormonal and cytokine markers (113), suggesting that the bacteria increase the cardiovascular risk
Nutritional Support and Hydration During Tirzepatide Therapy GLP-1 medications like tirzepatide can reduce appetite so significantly that some patients unintentionally under-eat or become dehydratedboth of which increase diverticulitis risk
Other causes include strict vegan diets, malabsorption disorders (coeliac disease, Crohn's disease), gastrointestinal surgery, and long-term use of medications such as metformin or proton pump inhibitors
MASLD Substudy Sanyal et al., Nature Medicine (2024) Sanyal and colleagues conducted a prespecified phase 2a substudy of the original phase 2 obesity trial, evaluating retatrutide in participants with metabolic dysfunction-associated steatotic liver disease (MASLD)
